KODIAK SCIENCES INC. Interest Expense
KODIAK SCIENCES INC. (KOD) reported Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-03-31
- KODIAK SCIENCES INC. interest expense for the quarter ending 2024-12-31 was $0.00.
- KODIAK SCIENCES INC. interest expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- KODIAK SCIENCES INC. interest expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- KODIAK SCIENCES INC. interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- KODIAK SCIENCES INC. interest expense for fiscal 2025 was $0.00.
- KODIAK SCIENCES INC. interest expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- KODIAK SCIENCES INC. interest expense for fiscal 2023 was $13.00K, a 27.78% decline from fiscal 2022.
- KODIAK SCIENCES INC. interest expense for fiscal 2022 was $18.00K, a 61.70% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | ||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $5.00K derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $5.00K derived: sum of 3 quarters · filed 2026-03-31 | $9.00K derived: sum of 4 quarters · filed 2026-03-31 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.00K derived: sum of 2 quarters · filed 2026-03-31 | $9.00K derived: sum of 3 quarters · filed 2026-03-31 | $13.00K 10-K · filed 2026-03-31 | |||
| 2023-09-30 | $5.00K 10-Q · filed 2024-11-14 | $9.00K derived: sum of 2 quarters · filed 2024-11-14 | $13.00K 10-Q · filed 2024-11-14 | $17.00K derived: sum of 4 quarters · filed 2025-03-27 | |||
| 2023-06-30 | $4.00K 10-Q · filed 2024-08-14 | $8.00K 10-Q · filed 2024-08-14 | $12.00K derived: sum of 3 quarters · filed 2025-03-27 | $16.00K derived: sum of 4 quarters · filed 2025-03-27 | |||
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-15 | $8.00K derived: sum of 2 quarters · filed 2025-03-27 | $12.00K derived: sum of 3 quarters · filed 2025-03-27 | $17.00K derived: sum of 4 quarters · filed 2025-03-27 | |||
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $8.00K derived: sum of 2 quarters · filed 2025-03-27 | $13.00K derived: sum of 3 quarters · filed 2025-03-27 | $18.00K 10-K · filed 2025-03-27 | |||
| 2022-09-30 | $4.00K 10-Q · filed 2023-11-14 | $9.00K derived: sum of 2 quarters · filed 2023-11-14 | $14.00K 10-Q · filed 2023-11-14 | $44.00K derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-14 | $10.00K 10-Q · filed 2023-08-14 | $40.00K derived: sum of 3 quarters · filed 2024-03-28 | $46.00K derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2022-03-31 | $5.00K 10-Q · filed 2023-05-15 | $35.00K derived: sum of 2 quarters · filed 2024-03-28 | $41.00K derived: sum of 3 quarters · filed 2024-03-28 | $46.00K derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2021-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $36.00K derived: sum of 2 quarters · filed 2024-03-28 | $41.00K derived: sum of 3 quarters · filed 2024-03-28 | $47.00K 10-K · filed 2024-03-28 | $22.00K 10-K · filed 2022-03-01 | ||
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-09 | $11.00K derived: sum of 2 quarters · filed 2022-11-09 | $17.00K 10-Q · filed 2022-11-09 | $23.00K derived: sum of 4 quarters · filed 2023-03-28 | |||
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-09 | $11.00K 10-Q · filed 2022-08-09 | $17.00K derived: sum of 3 quarters · filed 2023-03-28 | $23.00K derived: sum of 4 quarters · filed 2023-03-28 | |||
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-10 | $12.00K derived: sum of 2 quarters · filed 2023-03-28 | $18.00K derived: sum of 3 quarters · filed 2023-03-28 | $24.00K derived: sum of 4 quarters · filed 2023-03-28 | |||
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $12.00K derived: sum of 2 quarters · filed 2023-03-28 | $18.00K derived: sum of 3 quarters · filed 2023-03-28 | $25.00K 10-K · filed 2023-03-28 | |||
| 2020-09-30 | $6.00K 10-Q · filed 2021-11-09 | $12.00K derived: sum of 2 quarters · filed 2021-11-09 | $19.00K 10-Q · filed 2021-11-09 | $19.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-09 | $13.00K 10-Q · filed 2021-08-09 | $13.00K derived: sum of 3 quarters · filed 2022-03-01 | $15.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-10 | $7.00K derived: sum of 2 quarters · filed 2022-03-01 | $9.00K derived: sum of 3 quarters · filed 2022-03-01 | $11.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.00K derived: sum of 2 quarters · filed 2022-03-01 | $4.00K derived: sum of 3 quarters · filed 2022-03-01 | $8.00K 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $2.00K 10-Q · filed 2020-11-09 | $4.00K derived: sum of 2 quarters · filed 2020-11-09 | $8.00K 10-Q · filed 2020-11-09 | $198.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $2.00K 10-Q · filed 2020-08-10 | $6.00K 10-Q · filed 2020-08-10 | $196.00K derived: sum of 3 quarters · filed 2021-03-01 | $2.18M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $4.00K 10-Q · filed 2020-05-11 | $194.00K derived: sum of 2 quarters · filed 2021-03-01 | $2.18M derived: sum of 3 quarters · filed 2021-03-01 | $4.05M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.17M derived: sum of 2 quarters · filed 2021-03-01 | $4.05M derived: sum of 3 quarters · filed 2021-03-01 | $5.52M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $1.98M 10-Q · filed 2019-11-12 | $1.98K 10-Q · filed 2018-11-16 | $3.86M derived: sum of 2 quarters · filed 2019-11-12 | $5.33M 10-Q · filed 2019-11-12 | $5.33K 10-Q · filed 2018-11-16 | $6.51M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $1.88M 10-Q · filed 2019-08-14 | $3.35M 10-Q · filed 2019-08-14 | $4.53M derived: sum of 3 quarters · filed 2020-03-16 | $4.53M derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2018-03-31 | $1.47M 10-Q · filed 2019-05-15 | $2.65M derived: sum of 2 quarters · filed 2020-03-16 | $2.65M derived: sum of 3 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.18M derived: sum of 2 quarters · filed 2020-03-16 | $1.19M 10-K · filed 2020-03-16 | ||||
| 2017-09-30 | $395.00 10-Q · filed 2018-11-16 | $407.00 10-Q · filed 2018-11-16 | |||||
| 2016-12-31 | $6.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |